Ignite Creation Date:
2024-05-06 @ 10:33 AM
Last Modification Date:
2024-10-26 @ 12:31 PM
Study NCT ID:
NCT03281954
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-08
First Post:
2017-09-08
Brief Title:
Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
Sponsor:
NSABP Foundation Inc
Organization:
NSABP Foundation Inc
Organization Data
Organization:
NSABP Foundation Inc
Class:
NETWORK
Study ID:
NSABP B-59GBG 96-GeparDouze
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
NSABP Foundation Inc
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Hoffmann-La Roche | INDUSTRY |
| Genentech Inc | INDUSTRY |